HCC remains a leading cause of cancer-related mortality, and current AASLD/EASL guidelines recommend semi-annual surveillance in patients with cirrhosis, typically using ultrasound with or without serum alpha-fetoprotein (AFP) [27,28]. This evidence concerns the gene AFP and cancer.